• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Xylem Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    1/15/25 4:18:05 PM ET
    $XYL
    Fluid Controls
    Industrials
    Get the next $XYL alert in real time by email
    xyl-20250110
    0001524472false00015244722025-01-102025-01-10
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): January 10, 2025
    XYLEM INC.
    (Exact name of registrant as specified in its charter)
    Indiana001-3522945-2080495
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    301 Water Street SE20003
    WashingtonDC
    (Address of principal executive offices)(Zip Code)
    (202) 869-9150
    (Registrant’s telephone number, including area code)
    (Former name or former address, if changed since last report)

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange of which registered
    Common Stock, par value $0.01 per shareXYLNew York Stock Exchange

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    ☐Emerging growth company
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨



    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    On January 10, 2025, Jeanne Beliveau-Dunn informed the Board of Directors (the “Board”) of Xylem Inc. (the “Company”) of her decision not to stand for re-election as a Director of the Company at the Company’s 2025 annual meeting of shareholders (“2025 Annual Meeting”). Ms. Beliveau-Dunn’s decision not to stand for re-election is not because of any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. Ms. Beliveau-Dunn will continue to serve on the Board until the time of the 2025 Annual Meeting. Effective as of Ms. Beliveau-Dunn’s departure, the size of the Board shall be reduced to nine members.
    Item 9.01Financial Statements and Exhibits
    (d) Exhibits.
    Exhibit
       No.
    Description
    104.0The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL (included as Exhibit 101).





    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    XYLEM INC.
    Date: January 15, 2025By:/s/ Kelly C. O'Shea
    Kelly C. O'Shea
    Vice President, Chief Corporate Counsel and Corporate Secretary
    (Authorized Officer of Registrant)



    Get the next $XYL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $XYL

    DatePrice TargetRatingAnalyst
    5/30/2025$148.00Overweight
    Analyst
    12/12/2024Outperform → Peer Perform
    Wolfe Research
    12/9/2024$135.00 → $148.00Neutral → Buy
    Citigroup
    9/3/2024$138.00Buy → Hold
    TD Cowen
    8/13/2024$165.00Buy
    UBS
    3/12/2024$150.00Outperform
    Exane BNP Paribas
    1/4/2024Underperform → Mkt Perform
    Raymond James
    12/13/2023$127.00Outperform
    Wolfe Research
    More analyst ratings